Zirconium-89-labelled rituximab PET-CT in orbital inflammatory disease

BACKGROUND: Orbital inflammatory diseases are a heterogenic group of conditions that often entail a difficult diagnostic process and many patients are treatment resistant. Inflammatory diseases can be visualized by Zirconium-89-labelled rituximab PET-CT ((89)Zr-rituximab PET/CT). In this study, we d...

Descripción completa

Detalles Bibliográficos
Autores principales: Laban, Kamil G., Kalmann, Rachel, Leguit, Roos J., de Keizer, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667535/
https://www.ncbi.nlm.nih.gov/pubmed/31363937
http://dx.doi.org/10.1186/s13550-019-0530-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667535/
https://www.ncbi.nlm.nih.gov/pubmed/31363937
http://dx.doi.org/10.1186/s13550-019-0530-9

Ejemplares similares